Topical henna ameliorated capecitabine-induced hand-foot syndrome

被引:14
作者
Ilyas, Saher [1 ]
Wasif, Komal [1 ]
Saif, Muhammad Wasif [1 ]
机构
[1] Tufts Univ, Sch Med, Sect GI Canc & Expt Therapeut, Boston, MA 02111 USA
关键词
Capecitabine; diarrhea; hand-foot syndrome (HFS); pancreatic cancer; ALLERGIC CONTACT-DERMATITIS; 5-FLUOROURACIL; CONSTITUENTS;
D O I
10.3109/15569527.2013.832280
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Hand-foot syndrome (HFS) is the most frequently reported side effect of oral capecitabine therapy. In addition to treatment interruption and dose reduction, supportive treatments can help alleviate symptoms. Although its efficacy has not been proven in clinical studies, certain authors report on the use of prophylactic or therapeutic pyridoxine supplementation for the prevention of minimization to be useful in preventing worsening of HFS but are no substitute for dose modifications. Case report: We report a case of an interesting observation in a patient with pancreatic cancer receiving capecitabine whose HFS was improved with the use of "henna". Discussion: Henna has been used for histories as a medicine, preservative, and cosmetic. Our case underlines the basis to further evaluate the anti-inflammatory, antipyretic, and analgesic effects of henna. We encourage other investigators to publish any similar cases or any other herbal or non-drug therapies. HFS is a common side effect of many drugs, including capecitabine, sorafinib and regorafenib. HFS is bothersome for patients even in low grades and impacts quality of life of patients. HFS cannot be prevented and currently the treatments aimed at controlling syndrome are not very effective. Exploring other potential treatment or management options such as henna is of high value.
引用
收藏
页码:253 / 255
页数:3
相关论文
共 19 条
[1]   BULLOUS ALLERGIC CONTACT DERMATITIS TO PURE HENNA IN A 3-YEAR-OLD GIRL [J].
Belhadjali, Hichem ;
Akkari, Hayet ;
Youssef, Monia ;
Mohamed, Mariem ;
Zili, Jameleddine .
PEDIATRIC DERMATOLOGY, 2011, 28 (05) :580-581
[2]  
COMANDONE A, 1993, ANTICANCER RES, V13, P1781
[3]  
GORDON KB, 1995, CANCER, V75, P2169, DOI 10.1002/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO
[4]  
2-H
[5]   Henna (Lawsonia inermis Linn) inducing haemolysis among G6PD-deficient newborns. A new clinical observation [J].
Kandil, HH ;
AlGhanem, MM ;
Sarwat, MA ;
AlThallab, FS .
ANNALS OF TROPICAL PAEDIATRICS, 1996, 16 (04) :287-291
[6]  
Kazandjieva Jana, 2010, Skinmed, V8, P191
[7]  
Mikhaeil BR, 2004, Z NATURFORSCH C, V59, P468
[8]   Antifungal activity of the Algerian Lawsonia inermis (henna) [J].
Rahmoun, Nadjib ;
Boucherit-Otmani, Zahia ;
Boucherit, Kebir ;
Benabdallah, Mohammed ;
Choukchou-Braham, Noureddine .
PHARMACEUTICAL BIOLOGY, 2013, 51 (01) :131-135
[9]   Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency? [J].
Saif, A. Wasif ;
Diasio, Robert .
CLINICAL COLORECTAL CANCER, 2006, 5 (05) :359-362
[10]  
Saif M Wasif, 2005, Clin Colorectal Cancer, V5, P89, DOI 10.3816/CCC.2005.n.020